共 50 条
- [21] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults Dermatology and Therapy, 2017, 7 : 493 - 505
- [23] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
- [27] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis American Journal of Clinical Dermatology, 2023, 24 : 753 - 764